Literature DB >> 1750020

Results of thoracotomy in osteogenic sarcoma with pulmonary metastases.

S R Carter1, R J Grimer, R S Sneath, H R Matthews.   

Abstract

BACKGROUND Resection of pulmonary metastases may be followed by long term survival and now that it is an accepted method of treatment for patients with osteogenic sarcoma indicators of favourable prognosis are needed to aid the assessment of suitability for resection. This study compares the survival rates of patients who did and did not undergo resection of their pulmonary metastases and relates them to prognostic indicators. METHODS The study population was the 43 patients with osteosarcoma who developed pulmonary metastases out of the 111 patients with osteosarcoma treated by the Birmingham bone tumour treatment service during 1977-83. All patients who developed metastases confined to the lungs were considered for resection, thoracotomy being advised for all patients (provided that they were fit enough) who had metastases thought to be resectable even if they were multiple. RESULTS Of the 18 patients who did not have a thoracotomy, 15 died of disseminated disease after a mean interval of eight months; one patient died of cardiomyopathy and two are alive after 26 and eight months. Of the 25 patients who underwent thoracotomy in an attempt to resect metastases, three were found to have inoperable disease and died after a mean interval of 5.4 months from thoracotomy. Overall, after thoracotomy (repeated if necessary) there was a 20% survival at five years from the first thoracotomy. When survival was assessed with respect to the disease free interval and the number and bilaterality of the metastases no significant relationships were found. There was, however, a significant relation between survival and the position of metastases, patients with metastases confined to one lobe of the lung having a mean survival of 29.5 months, compared with 13.7 months in patients with disease in more than one lobe. CONCLUSION Thus patients who had a thoracotomy survived longer from the time of diagnosis of pulmonary metastasis than those not undergoing thoracotomy; metastases confined to one lobe predicted a better prognosis.

Entities:  

Mesh:

Year:  1991        PMID: 1750020      PMCID: PMC463392          DOI: 10.1136/thx.46.10.727

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  15 in total

1.  Osteogenic sarcoma under the age of twenty-one. A review of one hundred and forty-five operative cases.

Authors:  R C Marcove; V Miké; J V Hajek; A G Levin; R V Hutter
Journal:  J Bone Joint Surg Am       Date:  1970-04       Impact factor: 5.284

Review 2.  Causes of increased survival of patients with osteosarcoma: current controversies.

Authors:  M A Simon
Journal:  J Bone Joint Surg Am       Date:  1984-02       Impact factor: 5.284

3.  Pulmonary resection for metastatic sarcoma.

Authors:  J F Huth; E C Holmes; S E Vernon; C D Callery; K P Ramming; D L Morton
Journal:  Am J Surg       Date:  1980-07       Impact factor: 2.565

4.  Aggressive thoracotomy for pulmonary metastatic osteogenic sarcoma in children and young adolescents.

Authors:  M T Han; R L Telander; P C Pairolero; W S Payne; G S Gilchrist; F H Sim; D J Pritchard
Journal:  J Pediatr Surg       Date:  1981-12       Impact factor: 2.545

5.  Survival following aggressive resection of pulmonary metastases from osteogenic sarcoma: analysis of prognostic factors.

Authors:  J B Putnam; J A Roth; M N Wesley; M R Johnston; S A Rosenberg
Journal:  Ann Thorac Surg       Date:  1983-11       Impact factor: 4.330

6.  Osteogenic sarcoma: alterations in the pattern of pulmonary metastases with adjuvant chemotherapy.

Authors:  N Jaffe; E Smith; H T Abelson; E Frei
Journal:  J Clin Oncol       Date:  1983-04       Impact factor: 44.544

7.  Prognostic significance of complete surgical resection of pulmonary metastases in patients with osteogenic sarcoma: analysis of 32 patients.

Authors:  A M Goorin; M J Delorey; E E Lack; R D Gelber; K Price; J R Cassady; R Levey; D Tapper; N Jaffe; M Link
Journal:  J Clin Oncol       Date:  1984-05       Impact factor: 44.544

8.  Changing indications for bone scintigraphy in patients with osteosarcoma.

Authors:  H Goldstein; B J McNeil; E Zufall; N Jaffe; S Treves
Journal:  Radiology       Date:  1980-04       Impact factor: 11.105

9.  Combined chemotherapy and surgery for pulmonary metastases from osteogenic sarcoma. Results of 10 years experience.

Authors:  A N al-Jilaihawi; J Bullimore; M Mott; J D Wisheart
Journal:  Eur J Cardiothorac Surg       Date:  1988       Impact factor: 4.191

10.  Changing metastatic patterns of osteosarcoma.

Authors:  A E Giuliano; S Feig; F R Eilber
Journal:  Cancer       Date:  1984-11-15       Impact factor: 6.860

View more
  12 in total

1.  Prognosticating metastatic osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate and delayed metastasectomy: a single center experience of 102 patients.

Authors:  V Nataraj; S Rastogi; S A Khan; M C Sharma; S Agarwala; S Vishnubhatla; S Bakhshi
Journal:  Clin Transl Oncol       Date:  2016-01-07       Impact factor: 3.405

2.  Pulmonary metastases in children with osteosarcoma: characteristics and impact on patient survival.

Authors:  Darshana D Rasalkar; Winnie C W Chu; Vincent Lee; Bhawan K Paunipagar; Frankie W T Cheng; Chi Kong Li
Journal:  Pediatr Radiol       Date:  2010-09-03

3.  Location of pulmonary metastasis in pediatric osteosarcoma is predictive of outcome.

Authors:  Phillip A Letourneau; Lianchun Xiao; Matthew T Harting; Kevin P Lally; Charles S Cox; Richard J Andrassy; Andrea A Hayes-Jordan
Journal:  J Pediatr Surg       Date:  2011-07       Impact factor: 2.545

4.  Patients with osteosarcoma with a single pulmonary nodule on computed tomography: a single-institution experience.

Authors:  Israel Fernandez-Pineda; Najat C Daw; Beth McCarville; Liza J Emanus; Bhaskar N Rao; Andrew M Davidoff; Stephen J Shochat
Journal:  J Pediatr Surg       Date:  2012-06       Impact factor: 2.545

5.  Outcome of a pulmonary metastasectomy for an orthopedic malignancy.

Authors:  Ryuichi Suemitsu; Ichiro Yoshino; Makiko Tomiyasu; Kaoru Ondo; Hitoshi Ueda; Yukihide Iwamoto; Yoshihiko Maehara
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2005-08

6.  Significance of local treatment in patients with metastatic soft tissue sarcoma.

Authors:  Long Jiang; Shanshan Jiang; Yongbin Lin; Dongrong Situ; Han Yang; Yuanfang Li; Hao Long; Zhiwei Zhou
Journal:  Am J Cancer Res       Date:  2015-05-15       Impact factor: 6.166

7.  Outcome prediction of pulmonary metastasectomy can be evaluated using metastatic lesion in osteosarcoma patients.

Authors:  Isao Matsumoto; Makoto Oda; Tsuyoshi Yachi; Hiroyuki Tsuchiya; Yoh Zen; Go Watanabe
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

8.  Recurrent osteosarcoma with a single pulmonary metastasis: a multi-institutional review.

Authors:  N C Daw; A J Chou; N Jaffe; B N Rao; C A Billups; C Rodriguez-Galindo; P A Meyers; W W Huh
Journal:  Br J Cancer       Date:  2014-11-25       Impact factor: 7.640

9.  Prognostic value of monocyte and neutrophils to lymphocytes ratio in patients with metastatic soft tissue sarcoma.

Authors:  Long Jiang; Shanshan Jiang; Dongrong Situ; Yongbin Lin; Han Yang; Yuanfang Li; Hao Long; Zhiwei Zhou
Journal:  Oncotarget       Date:  2015-04-20

10.  A Phase II Study of Tumor Ablation in Patients with Metastatic Sarcoma Stable on Chemotherapy.

Authors:  Angela C Hirbe; Jack Jennings; Nael Saad; Joseph D Giardina; Yu Tao; Jingqin Luo; Shellie Berry; Jacqui Toeniskoetter; Brian A Van Tine
Journal:  Oncologist       Date:  2018-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.